Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 20 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

30%

6 trials in Phase 3/4

Results Transparency

25%

3 of 12 completed trials have results

Key Signals

5 recruiting3 with results

Enrollment Performance

Analytics

N/A
10(58.8%)
Phase 3
4(23.5%)
Phase 4
2(11.8%)
Phase 2
1(5.9%)
17Total
N/A(10)
Phase 3(4)
Phase 4(2)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (20)

Showing 20 of 20 trials
NCT06429332Phase 4Recruiting

International Care Bundle Evaluation in Cerebral Hemorrhage Research

Role: collaborator

NCT06320431Phase 3Recruiting

ACT-GLOBAL THROMBOLYSIS (ACT-WHEN-001) Domain Within the ACT-GLOBAL Adaptive Platform Trial-NCT06352632

Role: collaborator

NCT05564754Not ApplicableRecruiting

Sedation, Temperature and Pressure After Cardiac Arrest and Resuscitation

Role: collaborator

NCT06207942Not ApplicableRecruiting

Stepcare Extended Follow-up Substudy

Role: collaborator

NCT03734640Not ApplicableCompleted

Optimal Post Tpa-Iv Monitoring in Ischemic Stroke

Role: collaborator

NCT06003621Phase 2Recruiting

Tiragolumab and Atezolizumab in Advanced Pan-cancer Patients

Role: collaborator

NCT04497376Not ApplicableCompleted

Comparison Between Upgraded '2C3L' vs. PVI Approach for Catheter Ablation of Persistent Atrial Fibrillation

Role: collaborator

NCT03551327Not ApplicableCompleted

POst Stroke Intervention Trial In Fatigue (POSITIF)

Role: collaborator

NCT04567433Completed

Days Alive and Out of Hospital for Patients With Sepsis

Role: lead

NCT04347330Not ApplicableUnknown

Cardiovascular Risk Reduction in Atrial Fibrillation Trial

Role: collaborator

NCT04509973Phase 3Completed

Higher vs. Lower Doses of Dexamethasone for COVID-19 and Severe Hypoxia

Role: collaborator

NCT02065791Phase 3Completed

Evaluation of the Effects of Canagliflozin on Renal and Cardiovascular Outcomes in Participants With Diabetic Nephropathy

Role: collaborator

NCT03005509Not ApplicableCompleted

Structured Trauma Quality Improvement Meetings at Four Trauma Centres in India

Role: collaborator

NCT01989754Phase 4Completed

A Study of the Effects of Canagliflozin (JNJ-28431754) on Renal Endpoints in Adult Participants With Type 2 Diabetes Mellitus

Role: collaborator

NCT01032629Phase 3Completed

CANVAS - CANagliflozin cardioVascular Assessment Study

Role: collaborator

NCT02877342Unknown

Pre-hospital Notification of Injured Patients Presenting to Trauma Centres in India

Role: collaborator

NCT02002013Completed

The Fluid Translation of Research Into Practice Study

Role: lead

NCT02123875Not ApplicableCompleted

ATTEND-Family-led Rehabilitation After Stroke in India

Role: collaborator

NCT02021435Not ApplicableUnknown

Tibet Salt Reduction Study

Role: collaborator

NCT01020916Not ApplicableCompleted

Target Temperature Management After Cardiac Arrest

Role: collaborator

All 20 trials loaded